Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Monjuvi (tafasitamab-cxix) / Incyte

NCT01161511: Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia

	R/R CLL
	Dec 2014 - Dec 2014: R/R CLL
	In relapsed chronic lymphocytic leukemia
	Oct 2014 - Oct 2014: In relapsed chronic lymphocytic leukemia
	For chronic lymphocytic leukemia
	Dec 2012 - Dec 2012: For chronic lymphocytic leukemia
	Preclinical data for P1 trial at ASCO (B-cell malignancies)
	Jun 2012 - Jun 2012: Preclinical data for P1 trial at ASCO (B-cell malignancies)
	P1b trial completion
	May 2012 - May 2012: P1b trial completion
More

Completed

XmAb5574

Xencor, Inc.

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

01/13

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites